Evidence map›Paper›PMID 39272726›Full record

ReviewDiagnostics (Basel, Switzerland)2024

Radiotracer Innovations in Breast Cancer Imaging: A Review of Recent Progress.

Mohamad Haidar, Joe Rizkallah, Omar El Sardouk, Nour El Ghawi, Nadine Omran, Zeinab Hammoud, Nina Saliba, Arafat Tfayli, Hiba Moukadem, Ghina Berjawi and 6 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Mohamad HaidarDepartment of Diagnostic Radiology, American University of Beirut, Beirut 1107-2020, Lebanon.ORCID 0000-0001-6431-3274
Joe RizkallahDepartment of Diagnostic Radiology, American University of Beirut, Beirut 1107-2020, Lebanon.ORCID 0000-0001-9053-5866
Omar El SardoukDepartment of Diagnostic Radiology, American University of Beirut, Beirut 1107-2020, Lebanon.ORCID 0009-0005-5051-4282
Nour El GhawiDepartment of Diagnostic Radiology, American University of Beirut, Beirut 1107-2020, Lebanon.
Nadine OmranDepartment of Diagnostic Radiology, American University of Beirut, Beirut 1107-2020, Lebanon.
Zeinab HammoudDepartment of Diagnostic Radiology, American University of Beirut, Beirut 1107-2020, Lebanon.
Nina SalibaDepartment of Diagnostic Radiology, American University of Beirut, Beirut 1107-2020, Lebanon.
Arafat TfayliDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut, Beirut 1107-2020, Lebanon.
Hiba MoukademDivision of Hematology and Oncology, Department of Internal Medicine, American University of Beirut, Beirut 1107-2020, Lebanon.
Ghina BerjawiDepartment of Diagnostic Radiology, American University of Beirut, Beirut 1107-2020, Lebanon.
Lara NassarDepartment of Diagnostic Radiology, American University of Beirut, Beirut 1107-2020, Lebanon.
Fahad MarafiJaber Al-Ahmad Centre for Molecular Imaging, Kuwait City 70031, Kuwait.
Partha ChoudharyDepartment of Nuclear Medicine, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi 110085, India.
Habibollah DadgarCancer Research Center, RAZAVI Hospital, Imam Reza International University, Mashhad 9198613636, Iran.
Alyaa SadeqJaber Al-Ahmad Centre for Molecular Imaging, Kuwait City 70031, Kuwait.
Alain S Abi-GhanemDepartment of Diagnostic Radiology, American University of Beirut Medical Center, Beirut 1107-2020, Lebanon.ORCID 0000-0002-9004-807X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review focuses on the pivotal role of radiotracers in breast cancer imaging, emphasizing their importance in accurate detection, staging, and treatment monitoring. Radiotracers, labeled with radioactive isotopes, are integral to various nuclear imaging techniques, including positron emission tomography (PET) and positron emission mammography (PEM). The most widely used radiotracer in breast cancer imaging is

Indexed as

18F-fluorodeoxyglucosebreast cancermolecular imagingnuclear medicinepositron emission tomographyradiopharmaceuticalsradiotracerstumor detection

Identifiers

PMID39272726
PMCPMC11394464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.